BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12802611)

  • 1. The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma.
    Ozsarlak O; Tjalma W; Schepens E; Corthouts B; Op de Beeck B; Van Marck E; Parizel PM; De Schepper AM
    Eur Radiol; 2003 Oct; 13(10):2338-45. PubMed ID: 12802611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary uterine cervical cancer: correlation of preoperative magnetic resonance imaging and clinical staging (FIGO) with histopathology findings.
    Kraljević Z; Visković K; Ledinsky M; Zadravec D; Grbavac I; Bilandzija M; Soljacić-Vranes H; Kuna K; Klasnić K; Krolo I
    Coll Antropol; 2013 Jun; 37(2):561-8. PubMed ID: 23941005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment staging of cervical cancer: is imaging better than palpation?: Role of CT and MRI in preoperative staging of cervical cancer: single institution results for 255 patients.
    Hancke K; Heilmann V; Straka P; Kreienberg R; Kurzeder C
    Ann Surg Oncol; 2008 Oct; 15(10):2856-61. PubMed ID: 18696156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients.
    Kim SH; Choi BI; Han JK; Kim HD; Lee HP; Kang SB; Lee JY; Han MC
    J Comput Assist Tomogr; 1993; 17(4):633-40. PubMed ID: 8331236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.
    Hricak H; Gatsonis C; Chi DS; Amendola MA; Brandt K; Schwartz LH; Koelliker S; Siegelman ES; Brown JJ; McGhee RB; Iyer R; Vitellas KM; Snyder B; Long HJ; Fiorica JV; Mitchell DG; ;
    J Clin Oncol; 2005 Dec; 23(36):9329-37. PubMed ID: 16361632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging.
    Kamimori T; Sakamoto K; Fujiwara K; Umayahara K; Sugiyama Y; Utsugi K; Takeshima N; Tanaka H; Gomi N; Takizawa K
    Int J Gynecol Cancer; 2011 Feb; 21(2):349-54. PubMed ID: 21721193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
    Marnitz S; Tsunoda AT; Martus P; Vieira M; Affonso Junior RJ; Nunes J; Budach V; Hertel H; Mustea A; Sehouli J; Scharf JP; Ulrich U; Ebert A; Piwonski I; Kohler C
    Int J Gynecol Cancer; 2020 Dec; 30(12):1855-1861. PubMed ID: 33293284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Predictive Model for Parametrial Invasion in Patients With FIGO Stage IB Cervical Cancer: Individualized Approach for Primary Treatment.
    Kong TW; Piao X; Chang SJ; Paek J; Lee Y; Lee EJ; Ryu HS
    Int J Gynecol Cancer; 2016 Jan; 26(1):184-91. PubMed ID: 26512782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?
    Marnitz S; Köhler C; Roth C; Füller J; Hinkelbein W; Schneider A
    Gynecol Oncol; 2005 Dec; 99(3):536-44. PubMed ID: 16126259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Operable stage IB and II cancer of the uterine neck: retrospective comparison between preoperative utero-vaginal curietherapy and initial surgery followed by radiotherapy].
    Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Ganansia V; Bernard A; Antoine JM; Jannet D; Lhuillier PE; Uzan M; Genestie C; Antoine M; Jamali M; Milliez J; Uzan S; Blondon J
    Cancer Radiother; 2002 Jun; 6(4):217-37. PubMed ID: 12224488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comparison between clinical and CT staging in primary cervical carcinoma.
    Walsh JW; Goplerud DR
    AJR Am J Roentgenol; 1981 Nov; 137(5):997-1003. PubMed ID: 6975028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of magnetic resonance imaging in pretreatment evaluation of early-stage cervical cancer.
    Zhang W; Zhang J; Yang J; Xue H; Cao D; Huang H; Wu M; Cui Q; Chen J; Lang J; Shen K
    Int J Gynecol Cancer; 2014 Sep; 24(7):1292-8. PubMed ID: 24987919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiological evaluation of metastatic lymph nodes in carcinoma cervix with emphasis on their infiltrative pattern.
    Dhamija E; Baby A; Bhatla N; Pulappadi VP; Kumar M; Kumar S; Kumar L; Sharma D
    Indian J Med Res; 2021 Aug; 154(2):383-390. PubMed ID: 35295016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience].
    Bosković V; Glisić A; Petković S
    Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of carcinoma cervix using magnetic resonance imaging: correlation with clinical FIGO staging and impact on management.
    Dhoot NM; Kumar V; Shinagare A; Kataki AC; Barmon D; Bhuyan U
    J Med Imaging Radiat Oncol; 2012 Feb; 56(1):58-65. PubMed ID: 22339747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
    Sala E; Micco M; Burger IA; Yakar D; Kollmeier MA; Goldman DA; Gonen M; Park KJ; Abu-Rustum NR; Hricak H; Vargas HA
    Int J Gynecol Cancer; 2015 Oct; 25(8):1461-7. PubMed ID: 26397068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More accurate definition of clinical target volume based on the measurement of microscopic extensions of the primary tumor toward the uterus body in international federation of gynecology and obstetrics Ib-IIa squamous cell carcinoma of the cervix.
    Xie WJ; Wu X; Xue RL; Lin XY; Kidd EA; Yan SM; Zhang YH; Zhai TT; Lu JY; Wu LL; Zhang H; Huang HH; Chen ZJ; Li DR; Xie LX
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):206-12. PubMed ID: 25442332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT and ultra low field (0.02 T) MR imaging of uterine cervical carcinoma.
    Varpula M; Kilholma P; Klemi P
    Acta Radiol; 1994 Jul; 35(4):361-6. PubMed ID: 8011386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic imaging in invasive cervical carcinoma: MRI, CT, and ultrasonography].
    Michniewicz K; Oellinger J
    Zentralbl Gynakol; 2001 Apr; 123(4):222-8. PubMed ID: 11370531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
    Kim J; Cho Y; Kim N; Chung SY; Kim JW; Lee IJ; Kim YB
    Gynecol Oncol; 2021 Mar; 160(3):735-741. PubMed ID: 33358037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.